Holger Weis's most recent trade in Alaunos Therapeutics Inc was a trade of 130,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on July 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alaunos Therapeutics Inc | Holger Weis | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2025 | 130,000 | 130,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Holger Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2025 | 10,904 | 10,904 | - | - | Employee Stock Option (right to buy) | |
| Jupiter Neurosciences Inc | Holger Weis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2025 | 10,781 | 10,781 | - | - | Common Stock, par value $0.0001 per share | |
| Jupiter Neurosciences Inc | Holger Weis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2025 | 10,781 | 10,781 | - | - | Convertible Notes | |
| Alaunos Therapeutics Inc | Holger Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 19,200 | 19,200 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Holger Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 4,524 | 4,524 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Holger Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Holger Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Holger Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 160,167 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Holger Weis | Director | Purchase of securities on an exchange or from another person at price $ 1.83 per share. | 01 Sep 2021 | 50,000 | 120,167 (0%) | 0% | 1.8 | 91,500 | Common Stock |
| Alaunos Therapeutics Inc | Holger Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Holger Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 31,250 | 31,250 | - | - | Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Holger Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 4,167 | 70,167 (0%) | 0% | 0 | Common Stock |